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INTRODUCTION 
Childhood obesity 
Childhood obesity is one of the most serious public health 
challenges of the 21st century. The problem is global and is steadily 
affecting many low and middle income countries, particularly in urban 
settings. The prevalence has increased at an alarming rate. Globally, in 
2010 the number of overweight children under the age of five is estimated 
to be over 42 million. Close to 35 million of these are living in 
developing countries. 
Overweight and obese children are likely to stay obese into 
adulthood and more likely to develop diseases like diabetes and 
cardiovascular diseases at a younger age, the risks depend partly on the 
age of onset and on the duration of obesity. Obese children and 
adolescents suffer from both short-term and long-term health 
consequences.  
Consequences of an unhealthy lifestyle during childhood  
The most significant health consequences of childhood overweight 
and obesity, that often do not become apparent until adulthood, include: 
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• cardiovascular diseases (mainly heart disease and stroke); 
• diabetes; 
• musculoskeletal disorders, especially osteoarthritis; and 
• certain types of cancer (endometrial, breast and colon). 
The fundamental cause of childhood overweight and obesity is an 
energy imbalance between calories consumed and calories spent. 
Global increases in childhood overweight and obesity are 
attributable to a number of factors including: 
• A global shift in the diet towards increased intake of energy-dense 
foods that are high in fat and sugars but low in vitamins, minerals 
and other healthy micronutrients; 
• A trend towards decreased physical activity levels due to the 
increasing sedentary nature of many forms of recreation time, 
changing modes of transportation, and increasing urbanization. 
Metabolic syndrome:  
Metabolic syndrome is also known as metabolic syndrome X, 
syndrome X, insulin resistance syndrome, Reaven's syndrome is a 
combination of medical disorders that increase the risk of developing 
cardiovascular diseases and diabetes.  
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Although the pathophysiology of this syndrome is incompletely 
understood, insulin resistance and abdominal obesity are central to many 
of the metabolic perturbations. Based on existing estimates the metabolic 
syndrome affects- nearly 1/4th of the populations in developed countries 
(1). Prevalence of the metabolic syndrome is increasing in developing 
countries, including India (1, 2). The cluster of metabolic abnormalities 
comprising the metabolic syndrome is evident even in Asian Indian 
children and adolescents (3-5) 
  Insulin resistance and resulting hyperinsulinemia have been 
implicated in the development of glucose intolerance (and progression to 
type 2 diabetes), hypertriglyceridemia, hypertension, polycystic ovary 
syndrome, hypercoagulability and vascular inflammation, as well as the 
eventual development of atherosclerotic cardiovascular disease 
manifested as myocardial infarction, stroke and myriad end organ 
diseases. Conversely, treatment and consequent improvement of insulin 
resistance have been shown to result in better outcomes in virtually all of 
these conditions. The main features of metabolic syndrome include 
insulin resistance, hypertension, cholesterol abnormalities, and an 
increased risk for clotting. Patients are most often overweight or obese. 
Insulin resistance refers to the diminished ability of cells to respond to the 
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action of insulin in promoting the transport of glucose from blood into 
muscles and other tissues. 
Metabolic syndrome increases the risk of type 2 diabetes (the 
common type of diabetes) anywhere from 9-30 times over the normal 
population. That's a huge increase. As to the risk of heart disease, studies 
vary, but the metabolic syndrome appears to increase the risk 2-4 times 
that of the normal population.  
There are other concerns as well that should be mentioned. 
Metabolic syndrome is associated with fat accumulation in the liver (fatty 
liver), resulting in inflammation and the potential for cirrhosis. The 
kidneys can also be affected, as there is an association with 
microalbuminuria the leaking of protein into the urine, a subtle but clear 
indication of kidney damage.  
Other problems associated with metabolic syndrome include 
obstructive sleep apnea, polycystic ovary syndrome, increased risk of 
dementia with aging, and cognitive decline in the elderly.  
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Criteria of metabolic syndrome in children and adolescents 
Age 6 to <10 years 
• Obesity 90th percentile as assessed by waist circumference  
• Metabolic syndrome cannot be diagnosed, but further 
measurements should be made if family history of metabolic 
syndrome, type 2 diabetes mellitus, dyslipidaemia, cardiovascular 
disease, hypertension, or obesity  
• IDF suggests that a strong message for weight reduction should be 
delivered for those with abdominal obesity 
Age 10 to <16 years 
• Obesity 90th percentile (or adult cut-off if lower) as assessed by 
waist circumference  
• Triglycerides 1.7 mmol/L  
• HDL-cholesterol <1.03 mmol/L  
• Blood pressure 130 mm Hg systolic or ?85 mm Hg diastolic  
• Glucose 5.6 mmol/L (oral glucose tolerance test recommended) or 
known type 2 diabetes mellitus 
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Age >16 years 
Use existing IDF criteria for adults: 
According to the new IDF definition, for a person to be defined as 
having the metabolic syndrome they must have: 
Central obesity (defined as waist circumference* with ethnicity specific 
values) plus any two of the following four factors:   
• raised TG level: 150 mg/dL (1.7 mmol/L), or specific treatment 
for this lipid abnormality 
• reduced HDL cholesterol: < 40 mg/dL (1.03 mmol/L) in males 
and < 50 mg/dL (1.29 mmol/L) in females, or specific treatment for 
this lipid abnormality 
• raised blood pressure: systolic BP  130 or diastolic BP  85 mm 
Hg, or treatment of previously diagnosed hypertension 
• raised fasting plasma glucose (FPG)  100 mg/dL (5.6 mmol/L), 
or previously diagnosed type 2 diabetes (If above 5.6 mmol/L or 
100 mg/dL, OGTT is strongly recommended but is not necessary to 
define presence of the syndrome). 
* If BMI is >30kg/m², central obesity can be assumed and waist 
circumference does not need to be measured. 
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NCEP 
The US National Cholesterol Education Program Adult Treatment 
Panel III (2001) requires at least three of the following(6) 
• central obesity: waist circumference ≥ 102 cm or 40 inches (male), 
≥ 88 cm or 36 inches(female) 
• dyslipidemia: TG ≥ 1.7 mmol/L (150 mg/dl) 
• dyslipidemia: HDL-C < 40 mg/dL (male), < 50 mg/dL (female) 
• blood pressure ≥ 130/85 mmHg 
• fasting plasma glucose ≥ 6.1 mmol/L (110 mg/dl) 
American Heart Association/Updated NCEP 
There is confusion as to whether AHA/NHLBI intended to create 
another set of guidelines or simply update the NCEP ATP III definition. 
According to Scott Grundy, University of Texas Southwestern Medical 
School, Dallas, Texas, the intent was just to update the NCEP ATP III 
definition and not create a new definition (7, 8): 
• Elevated waist circumference:  
o Men — Equal to or greater than 40 inches (102 cm) 
o Women — Equal to or greater than 35 inches (88 cm) 
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• Elevated triglycerides: Equal to or greater than 150 mg/dL 
(1.7 mmol/L) 
• Reduced HDL (“good”) cholesterol:  
o Men — Less than 40 mg/dL (1.03 mmol/L) 
o Women — Less than 50 mg/dL (1.29 mmol/L) 
• Elevated blood pressure: Equal to or greater than 130/85 mm Hg or 
use of medication for hypertension 
• Elevated fasting glucose: Equal to or greater than 100 mg/dL 
(5.6 mmol/L) or use of medication for hyperglycemia 
WHO Criteria - the World Health Organization bases it's definition on 
presence of insulin resistance plus two of the following:  
• Insulin resistance : 
 Impaired fasting blood glucose (the American Diabetes 
Association considers the cutoff to be 100 mg/dL) Impaired 
glucose tolerance (blood glucose above 140 two hours after a 75g 
glucose challenge) A diagnosis of Type 2 diabetes is automatically 
included  
• High blood pressure (>=140 mm Hg systolic or >=90 mm Hg 
diastolic) or taking blood pressure medication  
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• Plasma triglycerides >=150 mg/dL (>=1.7 mmol/L)  
• HDL cholesterol <35 mg/dL (<0.9 mmol/L) in men or <39 mg/dL 
(1.0 mmol/L) in women  
• BMI greater than 30 and/or waist:hip ratio >0.9 in men, >0.85 in 
women  
• Urinary albumin excretion rate >=20 µg/min or albumin:creatinine 
ratio >=30 mg/g 
Relationship among metabolic syndrome components 
Overweight and increased plasma insulin are key components of 
the metabolic syndrome(11,12) Bao et al(12)  studied > 1,500 individuals 
in the Bogalusa Heart Study initially when they were 5-23 years of age 
and then again 8 years later. They found that subjects with consistently 
high insulin levels had 36 times more overweight, 2.5 times more 
hypertension,3 times more dyslipidemia than those with low insulin 
levels. Other studies also support a link among obesity, hyperinsulinemia, 
and other metabolic syndrome components in youth(9,10,13) 
Not only are overweight and hyperinsulinemia associated, but the 
two factors are also related to dyslipidemia, especially low HDL 
cholesterol and high triglyceride levels(9,14,15,16). In several studies, 
overweight youth had higher serum insulin (with normal glucose), higher 
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triglycerides and blood pressure, and lower HDL cholesterol than non 
overweight subjects(9,10). 
Hypertension is recognized as an important component of the 
metabolic syndrome in adults, but its role in the syndrome in children and 
adolescents is not clear. Few studies of youth have examined the 
relationship of blood pressure and insulin values, and their results are 
conflicting. Some investigators found a positive association between 
insulin levels and blood pressure(14,17,18)where as others have 
not(19,20) 
Overweight children had low HDL cholesterol and high 
triglycerides and insulin, but normal glucose levels(9,10)suggesting that 
glucose intolerance may develop later than other syndrome abnormalities. 
Thus, it may be important to assess insulin levels as well as glucose in 
children, because many with the cluster of metabolic syndrome factors 
will have normal glucose levels. 
The mechanism responsible for the development of insulin 
resistance in children and adolescents is not well understood. In adults, 
the mechanism defect associated with insulin resistance occurs on several 
levels: 1) pre-receptor defect (defective insulin production), 2) receptor 
defect (decreased or defective receptor sites), 3) glucose transport defect 
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(abnormal GLUT4 molecules), or 4) post-receptor defect (abnormal 
signal transduction) (Granberry & Fonseca, 1999). Abnormalities of the 
insulin molecule are extremely rare. A decreased number of receptor sites 
as well as defects in post-receptor signaling are more frequently seen in 
individuals with insulin resistance. Defects in post-receptor signaling 
often are found in individuals with central obesity and a sedentary 
lifestyle - two known risk factors for many of the disorders associated 
with Insulin resistance syndrome (Granberry & Fonseca, 1999). Evidence 
now exists that these mechanical defects occur in children as well by as 
early as 6-10 years of age (Uwaifo et al., 2002). 
Hypertension 
 The relation between hypertension and insulin resistance 
is confounded by the significant independent relation between 
hypertension and obesity. Hypertension is an integral component of 
the MetS(21) Increased sympathetic tone has been associated with 
obesity in adolescents, and both insulin and leptin(22) appear to have a 
direct effect on sympathetic nervous system activity(23). Insulin infusions 
stimulate sodium retention by the kidney, and insulin stimulates vascular 
smooth muscle growth. Fasting insulin, used as an estimate of insulin 
resistance, has been significantly correlated with blood pressure in 
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children and adolescents(24). The Cardiovascular Risk in Young Finns 
study showed a significant correlation between fasting insulin and blood 
pressure in children and adolescents and also showed that the level of 
fasting insulin predicted the level of blood pressure 6 years 
later. Similarly, leptin has direct central effects that increase 
sympathetic outflow to the kidney. It has been hypothesized that 
selective leptin resistance maintains leptin-induced sympathetic 
activation in obesity, which permits leptin to play an important role in the 
pathogenesis of obesity-related hypertension and MetS. Studies in 11- to 
15-year-olds showed a lack of significant correlations for blood pressure 
with fasting insulin (adjusted for BMI), insulin resistance (measured with 
the euglycemic clamp), triglycerides, HDL-C, and low-density lipoprotein 
(LDL) cholesterol. However, when the MetS factors (triglycerides, HDL-
C, fasting insulin, and BMI) were considered together as a cluster 
and comparisons made between children with high and low blood 
pressure, the cluster score was significantly higher in the high 
blood pressure group. Thus, despite the lack of a significant 
relation between blood pressure and the individual risk factors, its relation 
with the cluster of risk factors is consistent with a clinical association of 
blood pressure and the MetS before adulthood. Most recently, the Fels 
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Longitudinal Study showed a strong association between childhood 
hypertension and adult MetS(25). 
Lipid Abnormalities 
Lipid abnormalities, particularly high triglycerides and low HDL-
C, are strongly associated with insulin resistance(26) and are criteria for 
the MetS. Studies in rats have shown that hyperinsulinemia stimulates the 
synthesis of fatty acids by increasing the transcription of genes for 
lipogenic enzymes in the liver. Fatty acids in turn stimulate increased 
production of very-low-density lipoprotein. It is currently unknown 
whether insulin resistance induces dyslipidemia or whether insulin 
resistance and dyslipidemia are associated via an underlying cause. 
Abnormal lipid profiles also are found in children with obesity and 
insulin resistance (27,28). Data from the Bogalusa Heart Study have 
shown that overweight children have significantly higher levels of total 
cholesterol, LDL cholesterol, and triglycerides and lower HDL-C levels 
than normal-weight children (29). The hypertriglyceridemic waist 
phenotype has been proposed in adults as a predictor of the MetS. A 
recent study in more than 3000 adolescents that used the modified ATP 
III cut points for serum triglycerides ( 110 mg/dL) and waist 
circumference ( 90th percentile for age and sex) has shown that the 
14 
 
concomitant presence of these criteria was significantly associated with a 
clustering of metabolic abnormalities, which is characteristic of the MetS 
Apo lipoprotein CIII, a marker of the triglyceride-rich 
lipoproteins increased in MetS, retards triglyceride clearance. This 
may explain why there is a preponderance of small, dense LDL 
particles in the setting of MetS along with hypertriglyceridemia. 
Small, dense LDL particles may have increased atherogenic potential, and 
the mechanisms proposed for this association are their low affinity to 
LDL receptors, propensity to undergo oxidative stress, prolonged plasma 
half-life, and high penetration of the intima. In adults and more recently 
in children, a high prevalence of small, dense LDL particles was 
demonstrated in association with abdominal obesity, visceral fat, and 
insulin resistance. Hypertriglyceridemia is less frequent in blacks, which 
complicates the determination of appropriate cutoffs for the diagnosis 
of Mets(30). Independent of weight and insulin status, blacks have lower 
apolipoprotein CIII levels than other racial subgroups. Accordingly, 
lower apolipoprotein CIII levels in blacks correlate with less hepatic 
lipase degradation of triglyceride-rich precursors and less production of 
small, dense LDL. And yet, LDL lipoprotein sizing still correlates with 
triglyceride levels in blacks, just in a different range. These findings 
suggest that perhaps different lipid thresholds should be used for blacks, 
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because their lower incidence of dyslipidemia, as currently defined, does 
not lower their risk for T2DM(31) or cardiovascular morbidity(32). 
Glucose Intolerance: T2DM 
Diabetes mellitus, a metabolic disease characterized by 
hyperglycemia, is associated with accelerated development of vascular 
disease. Because insulin is the only significant hypoglycemic 
hormone, hyperglycemia is the result of either impaired secretion 
of insulin (type 1), resistance to the effect of insulin in liver or muscle 
(type 2), or a combination of these pathophysiological situations. 
The progression from insulin resistance and impaired 
carbohydrate metabolism to T2DM has been documented in 
adults and children (33,34) In adults, weight loss has been shown to 
reverse this progression, with frank diabetes regressing to 
insulin resistance. Patients with impaired fasting glucose or 
impaired glucose tolerance are referred to as "prediabetic," which 
acknowledges the relatively high risk for development of frank 
diabetes(35) With the current obesity epidemic and its metabolic 
consequences, the identification of children with impaired fasting 
glucose, that is, fasting glucose 100 to 126 mg/dL , is very important, 
because appropriate management may decrease the progression to T2DM. 
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Nevertheless, not all children with impaired carbohydrate metabolism 
develop T2DM. In a study of children with impaired glucose tolerance 
followed up over a period of 1 year, one third became euglycemic, one 
third developed T2DM, and one third maintained impaired glucose 
tolerance (36) Data from the Third National Health and Nutrition 
Examination Survey (NHANES III) reveal that the prevalence of type 1 
diabetes mellitus in adolescents is 1.7/1000, whereas the prevalence of 
T2DM is 4.1/1000. This increase coincides with increasing rates of 
overweight and physical inactivity in children (37). 
Mechanism: 
The mechanisms underlying the metabolic syndrome are not fully 
known; however resistance to insulin stimulated glucose uptake seems to 
modify biochemical responses in a way that predisposes to metabolic risk 
factors. A central role has been attributed to the pro-inflammatory 
cytokines, tumor necrosis factor a (TNF- a) and interleukin (IL)-6, 
supported by the fact that both are produced in substantial amounts by 
human adipose tissue. TNF- a impairs insulin-stimulated glucose uptake 
in a variety of cells and decreases lipoprotein lipase activity. Both 
cytokines increase hepatic lipogensis and elicit a systemic acute- phase 
response. Furthermore, various aspects of the acute-phase response, such 
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as fibrinogen and plasminogen activator inhibitor-1 levels, whole-blood 
viscosity, and white blood cell count, have recently been found to 
correlate positively with the metabolic syndrome. This is of particular 
interest because inflammation plays an important role in the pathogenesis 
of atherothrombosis.(38,39) 
Macrophage and T-cell infiltration is a major feature of 
atherosclerotic plaques, especially at sites of plaque rupture, and 
epidemiological studies show strong positive associations of systemic 
markers of inflammation with atherothrombotic disease(40,41) Moreover, 
C-reactive protein (CRP), the classic and exquisitively sensitive acute 
phase reactant, shows a strong independent association with the risk of 
Coronary Heart Disease and other atherothrombotic events. CRP levels 
have also been found to correlate with BMI and some features of the 
metabolic syndrome. 
The AHA/NHLBI/ADA conference identified three potential 
etiologic categories: 
1. Obesity and disorder of adipose tissue. 
2. Insulin-resistance 
3.  A constellation of independent risk factors (e.g. molecules of 
hepatic, vascular and immunologic origin) that mediate specific 
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component of syndrome like hypertension, prothrombotic state, 
lipoprotein metabolic ageing and physical inactivity. Metabolically, 
several risk factors tend to cluster in middle-aged adults, including HDL-
C, BMI, systolic pressure, TGs, glucose and cholesterol. Risk factors 
occur in isolation only 30% of the time, and clustering of three or more 
factors occurs 17% of the time in both genders. Clustering of the factors 
was related to baseline obesity and weight gain during adulthood. Loss of 
weight over a 16-year period was highly related to a reduced tendency 
toward clustering of risk factors. In addition, clusters of risk factors were 
related to greater risk of CHD over the follow up period, and the presence 
of 3 or more metabolic risk factors led to a doubling of risk for CHD in 
men and a five-fold increase in risk for women. In Framingham and in 
other observational studies, the central core of metabolic risk factors were 
found to be highly related, including triglycerides, HDL-C, BMI, waist 
circumference, or fasting insulin levels, to insulin levels after an oral 
glucose challenge test. In addition to a central metabolic syndrome core, 
there has been a hypertension cluster with shared variance components 
that included BMI, systolic pressure and diastolic pressure (42) Risk 
factors for metabolic syndrome 
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Heredity 
              Children of parents with metabolic syndrome( MetS) and 
increased cardiovascular risk may be at especially high risk of developing 
MetS and greater levels of cardiovascular risk factors themselves because 
of shared genetic and environmental factors(43,44,45) Familial influences 
on development of cardiovascular risk are well known. Because 
atherosclerotic cardiovascular disease(ASCVD) - aggregates in 
families, parental history of ASCVD is accepted as a measure of the 
offspring’s cardiovascular risk and has been used in prevention and 
intervention algorithms. The Bogalusa Heart Study has shown that 
offspring of parents with early coronary artery disease were 
overweight beginning in childhood and developed an adverse 
cardiovascular risk profile (elevated total cholesterol, LDL cholesterol, 
and plasma glucose)46 In addition, children and young adults with a 
parental history of premature ASCVD had higher blood pressure, serum 
lipids, and homocysteine than those with a negative 
parental history. Twin and family studies have found substantial familial 
aggregation for the MetS risk factors(43,44,45)Measures of preclinical 
atherosclerosis such as c-IMT and functional brachial artery flow-
mediated vasodilation showed evidence of early adverse changes in 
children of parents with premature ASCVD. Conversely, most obese 
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children have at least 1 parent who is obese, and the risk of adult obesity 
among children <10 years old is more than doubled if a parent is 
obese. The familial nature of insulin action in Pima Indians has 
been known for many years. Relatives of diabetic patients tend to have 
higher insulin levels than relatives of nondiabetic individuals. A positive 
family history of T2DM was associated with higher levels of insulin 
resistance (insulin clamp studies) in 10-year-old black children (47)In a 
study of 357 children and 378 parents (221 mothers and 157 
fathers), children who had at least 1 parent with the MetS (defined 
by ATP III criteria) had significantly higher levels of obesity, particularly 
central obesity, and insulin resistance than children in whom neither 
parent had the MetS.   
Lifestyle Behaviors 
Television-Watching Habits 
Epidemiological studies provide evidence that sedentary 
behavior, such as television watching, is positively associated with 
overweight among children and adults(48,49,50) although it is 
unknown whether watching television contributes to the development 
of insulin resistance and inflammation. In a recent study conducted among 
parents and their children enrolled in the Minnesota Heart Survey, 
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children who watched at least 1 hour of television per day and had 1 or 2 
overweight parents were at 15% or 32%, respectively, greater risk of 
being overweight than children with normal 
weight parents(51). Furthermore, for each hour of television watched per 
day, the likelihood of a child being overweight increased 2%; overweight 
parents watched more television than normal-weight parents. 
Physical-Activity  
Physical activity is beneficial for weight management and 
prevention of overweight and obesity in adults and children. There 
is evidence for an association between physical activity and lower levels 
of inflammatory cytokines and markers of oxidative stress. Higher levels 
of physical activity are also positively correlated with insulin sensitivity 
in adolescents(52) and with improved endothelial function and HDL-C, 
even in the absence of weight loss. However, most of these data are cross-
sectional, and few studies have directly assessed the effect of exercise 
training on these variables. Many of the controlled intervention 
studies addressing this issue have shown that exercise improves 
adipokine and oxidative stress levels; however, most of these trials 
have reported concomitant improvements in body weight or 
composition that occurred during the exercise training period. Because 
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adipocytes are the main mediators of these hormones, changes in body 
weight/composition confound the data with regard to the direct effects of 
exercise on these variables. Three studies have recently challenged 
the notion that exercise directly stimulates improvements in 
adipokines and inflammatory markers in adults and 
children(53) independent of weight loss. 
Dietary Intake 
Increased consumption of whole grain foods decreases the 
development of coronary heart disease and diabetes and improves 
insulin sensitivity and inflammation in adults. In a recent study among 
adolescent boys and girls, greater insulin sensitivity was observed with 
higher  intake of whole grain after adjustment for age, sex, race, Tanner 
stage, energy intake, and BMI. The same relation was noted among the 
overweight and obese adolescents(54), as well as in adults. A 
significant inverse association between fiber intake and the MetS has 
been described in adults and in the Framingham Offspring 
Study. Conversely, the prevalence of the MetS is significantly 
higher among individuals in the highest relative to the lowest 
quintile category of glycemic index. In 1 study, fiber attenuated the 
insulin response to ingested carbohydrate, with beneficial effects on 
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insulin sensitivity, adiposity, and pancreatic function, and it promoted 
satiety. There is evidence that a diet rich in fruit and vegetables, and 
therefore, antioxidants and micronutrients in addition to fiber, reduces the 
risk of ASCVD. Studies in adults have shown inverse relations of 
inflammatory factors with vitamin C, carotene, magnesium, and long-
chain fatty acids. Because we do not eat just 1 nutrient or 1 food, it is 
important to examine the role of dietary patterns and their relation 
with health outcomes. Previous studies in adults have shown a 
Western dietary pattern (a diet high in red and processed meat, fried food, 
high-fat dairy foods, and sugar-sweetened beverages) to be associated 
with adverse levels of cardiovascular risk factors, higher BMI, and higher 
all-cause, ASCVD, and cancer mortality. Conversely, a Mediterranean 
diet rich in fruits, vegetables, whole grains, and fish, supplemented with 
olive oil or nuts, has beneficial effects on cardiovascular risk 
factors Despite these presumed benefits, well-controlled studies in adults 
and children on the effect of these nutrients on risk for ASCVD are 
lacking. A recent scientific statement from the American Heart 
Association provides nutrition recommendations for the promotion of 
cardiovascular health in children and adolescents and is focused on total 
caloric intake and eating behaviors as part of a comprehensive healthy 
lifestyle(55). 
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Puberty and the metabolic syndrome 
Puberty presents a unique challenge to insulin-glucose 
homeostasis. During puberty, insulin resistance is increased, and insulin 
sensitivity is reduced in both nondiabetic and diabetic children. This 
insulin resistance is normally compensated for by increased insulin 
secretion(56,57,58)Caprio et al(57) suggested that the insulin 
hypersecretion they found in adolescents may reflect the puberty-
associated increase in the amount of circulating growth hormone. Travers 
et al(59) found that changes in insulin sensitivity during puberty were 
sex-dependent and suggested that they are related to changes in body 
composition.  
Body fat, blood pressure, and lipids are all affected by puberty. The 
percentage of body fat increases strikingly in females through 
adolescence, but changes in body fat in males are not consistent(60) 
Systolic blood pressure also rises with pubertal stage independent of age, 
particularly in girls(61,62)Lipids vary by pubertal stage in youth(63,64) 
For example, total cholesterol drops in mid-puberty and begins rising 
toward adult levels at the end of puberty(64,65)These lipid changes 
through puberty complicate the definition of cut-off points for 
dyslipidemia in youth. In addition, the changes in body fat, blood 
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pressure, and lipid profiles during puberty may be influenced by the 
decrease in physical activity and changes in eating habits that are 
commonly seen during adolescence (66,67).Thus, puberty is a crucial 
time for the development of the metabolic syndrome, and yet it is a 
difficult time during which to identify it.  
PREVENTION: 
General recommendations include decreasing obesity, increasing 
physical activity, and consuming an anti-atherogenic diet, and have 
traditionally focused on low total fat intake. A major problem with the 
focus on low fat is that high-carbohydrate diets can contribute to 
increasing triglyceride and decreasing high-density lipoprotein (HDL) 
concentrations. Low-carbohydrate diets have been popular in recent 
years. However, such diets are typically higher in saturated fat and lower 
in fruits, vegetables, and whole grains than national dietary 
recommendations. More recently the quality of carbohydrate has been 
studied in relation to MetS, including a focus on dietary fiber and 
glycemic index. Similarly, there has been a move from limiting total fat 
to a focus on the quality of the fat, with evidence of beneficial effects of 
replacing some carbohydrate with monounsaturated fat. Other nutrients 
examined for possible importance include calcium, vitamin D, and 
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magnesium. Together, the evidence suggests that the components of diet 
currently recommended as "healthy" are likely also protective against 
MetS, including low saturated and trans fat (rather than low total fat) and 
balanced carbohydrate intake rich in dietary fiber, as well as high fruit 
and vegetable intake (rather than low total carbohydrate); and the 
inclusion of low-fat dairy foods. Accelerating research on gene-diet 
interactions is likely to contribute interesting information that may lead to 
further individualized dietary guidance in the future. 
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1. In weiss et al “obesity and the metabolic syndrome in children 
and adolescents “study done in yale , university  school  of medicine , 
with 439 obese children and adolescents beginning in 1999 in the age 
group of 4 to 20 yrs showed the  over all prevelance of metabolic 
syndrome was 38.7% in moderately obese subjects and 49.7% in severely 
obese subjects. No overweight or non obese subjects met the criteria for 
metabolic syndrome .They used national cholesterol  education 
programme (1)adult treatment panel for defining metabolic syndrome. 
The prevalence increased significantly with increased insulin resistance 
after adjustment for race or ethnic group and the degree of obesity. C 
reactive protein levels and adiponectin levels decreased with increased 
obesity. They followed up 77 subjects after a mean (+/- sd) interval of 
21.5 +_ 10.5 months. 16 out of 43 who did not have metabolic syndrome 
at the time of initial evaluation developed it in follow up. 8 of whom who 
had impaired glucose tolerance during 1st visit developed type 2 diabetes 
mellitus during follow up(68) 
2. In cook et al -Analyses of cross-sectional data obtained from the 
Third National Health and Nutrition Examination Survey (1988-1994), 
which was administered to a representative sample of the 
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noninstitutionalized civilian population of the United States, the initial 
sample consisted of 3211 subjects aged 12 to 19 years, to whom the 
following exclusion criteria were applied: (1) had not fasted for 6 hours, 
(2) was currently pregnant, or (3) was taking medication classified as a 
blood glucose regulator, such as insulin, androgens or anabolic steroids, 
or adrenal corticosteroids. The final sample numbered 2430, including 
some individuals with 1 or more excluding factors. No children younger 
than 12 years were instructed to fast as part of NHANES III. criteria for 
the metabolic syndrome in adults specified by NCEP's ATP III and the 
adapted definition used in this analysis for adolescents aged 12 to 19 
years. 
The overall prevalence of the metabolic syndrome in adolescents 
was 4.2%. It was more common in males (6.1%) than in females (2.1%) 
and was more frequent in Mexican Americans (5.6%) and whites (4.8%) 
than black subjects (2.0%). In this sample, 41% of subjects had 1 or more 
of these risk factors, whereas 14% had 2 or more. There were no subjects 
who had all 5 of these risk factors. Overall, high triglyceride levels and 
low HDL cholesterol levels were most common, whereas high fasting 
glucose levels were the least common. White adolescents had the highest 
rates of high triglyceride levels (25.5%) and low HDL cholesterol levels 
(26.1%). Mexican American subjects had the highest rate of abdominal 
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obesity by waist circumference (13.0%). Black adolescents had the 
highest proportion of elevated blood pressure (6.2%). Adolescents with 
the metabolic syndrome had a mean BMI of 30.1 and, on average, were at 
the 95.5th percentile for BMI by age and sex . Of those adolescents who 
fulfilled these criteria for the metabolic syndrome, 25.2% were at risk for 
overweight, by BMI, and 73.9% were overweight(69) 
3. Based on Beijing Child and Adolescent Metabolic Syndrome 
(BCAMS) study with body mass index (BMI), waist circumference (WC) 
and blood pressure measured, the overweight and obese children were 
screened among nearly 20 000 children 6-18 years of age in Beijing by 
Chinese BMI cutoffs for schoolchildren (7-18 years) and the US 2000 
CDC Growth Charts--the 85th and 95th percentile (6 years) and were 
enrolled as the study population. Simultaneously a group of children with 
normal BMI were selected as the control group and based on the 
international method of age grouping, each of the above groups was 
divided further into 4 sub-groups in terms of age: 6-9, 10-12, 13-15 and 
16-18 years old, respectively. Fasting plasma glucose (FPG) and insulin 
(FINS), serum high-density lipoprotein cholesterol (HDL-C) and 
triglyceride (TG) were examined. HOMA-IR index was calculated for 
estimating individual insulin resistance. A child who met any three or 
more of the following five criteria, according to NCEP definition, was 
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diagnosed as MS. A diagnosis of MS using IDF definition required 
abdominal obesity plus any two or more of the other four criteria: (1) 
abnormal obesity: WC > or = P(90); (2) elevated BPs: SBP/DBP > or = 
P(90); (3) low HDL-C: HDL-C < 1.03 mmol/L (40 mg/dl); (4) high TG: 
TG > or = 1.24 mmol/L (110 mg/dl); (5) impaired fasting glucose (IFG): 
FPG > or = 5.6 mmol/L (100 mg/dl). 
The prevalence rates of MS by NCEP definition were: 0.9%, 7.6% 
and 29.8% in the normal weight (control group), overweight and obese 
children, respectively, which were higher than the rates diagnosed by IDF 
definition with 0.1%, 5.2% and 28.6% in the three groups. The 
prevalence rates of individual MS component among obese children 
were: 81.6% for abnormal obesity, 47.7% for elevated BPs, 35.6% for 
high TG, 16.9% for low HDL-C, and 13.4% for IFG. Elevated BPs 
(29.8%), abnormal obesity (27.4%) and high TG (26.0%) were the 
leading three abnormalities among overweight children. With the increase 
of BMI, the clustering of MS components and insulin resistance (HOMA-
IR) were remarkably increased. HOMA-IR significantly increased as the 
number of MS component increased(70) 
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4. In the cross sectional study done in turkey by semiz serap et al 
from From the Departments of Pediatric Endocrinology Pamukkale 
University School of Medicine, Denizli, Turkey. 
86 obese children (97 females and 89 males), aged 11.2 ± 2.8 (6-16) years 
and 98 healthy children (46 females and 52 males), aged 10.9 ± 3.2 (6-16) 
years were recruited for the study, as study and control groups, 
respectively. Methods: Subjects were evaluated for anthropometry, blood 
pressure (BP) and biochemical cardiovascular risk factors. Metabolic 
syndrome was defined in presence of 3 of the following: (i) fasting 
triglyceride 100 mg/dL; (ii) high density lipoprotein – cholesterol < 50 
mg/dL, except in boys aged 15 to 19 years, in whom the cut-off point was 
45 mg/dL; (iii) fasting glucose  110 mg/dL; (iv) waist circumference > 
75th percentile for age and gender and (v) systolic BP > 90th percentile. 
Hypertension, hyperinsulinemia, hyper-cholesterolemia, 
hypertriglyceridemia, low HDL-C, and high LDL-C frequencies of the 
obese children were significantly higher than those of control group in 
both sexes. Elevated systolic and diastolic blood pressures were detected 
in 17.7% and 15.1% of obese children, respectively. Hyperinsulinemia 
was shown in 52.2%. There was no subject with diabetes mellitus. 
Impaired glucose tolerance was found only in 1 (0.5%) subject. 11.3% of 
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the obese children had high TC, 25.8% had high TG, 36.6% had low 
HDL-C, and 3.7% had high LDL-C. 
The prevalence of metabolic syndrome was 2.1% in obese children. 
We detected that 79.0% of the obese children had one, two or more risk 
factors; the rest (20.9%) were free from any risk factor. These frequencies 
were much lower in the control group. The clustering of one, two and 
three risk factors was very rare - 12.2%, 7.1% and 0%, respectively(71) 
5. Margoth Caceres et al studied 61 obese children and 
adolescents aged between 5 and 18 years old. All children underwent an 
oral glucose tolerance test and fasting blood sample was also obtained to 
measure insulin, HDL, LDL and triglycerides serum level. The diagnosis 
of metabolic syndrome was defined according to National Cholesterol 
Education Program-Adult Treatment Panel (NCEP-ATP III) criteria 
adapted for children. 
Metabolic syndrome was found in 36% of the children, with a 
higher rate among males (40%) than females (32.2%) (p = 0.599). The 
prevalence of each of the components was 8.2% in impaired glucose 
tolerance, 42.6% for high triglyceride level, 55.7% for low levels of high-
density lipoprotein cholesterol, and 24.5% for high blood pressure. 
Insulin resistance (HOMA-IR > 3.5) was found in 39.4% of the children, 
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with a higher rate in males (50%) than females (29%). A strong 
correlation was found between insulin resistance and high blood pressure 
(p = 0.0148) and high triglycerides (p = 0.002). No statistical significance 
was found between the presence of acanthosis nigricans and insulin 
resistance. Acanthosis nigricans was found in (70%) of patients resistant 
to insulin, but it was also present in 54% of patients sensitive to insulin (p 
= 0.14)(72) 
6. de Ferranti, et al . defined pediatric MetS using criteria 
analogous to ATP III as 3 of the following: (1) fasting triglycerides 1.1 
mmol/L (100 mg/dL); (2) HDL <1.3 mmol/L (50 mg/dL), except in boys 
aged 15 to 19 years, in whom the cutpoint was <1.2 mmol/L (45 mg/dL); 
(3) fasting glucose 6.1 mmol/L (110 mg/dL); (4) waist circumference 
>75th percentile for age and gender; and (5) systolic blood pressure >90th 
percentile for gender, age, and height. MetS prevalence in US adolescents 
was estimated with the Third National Health and Nutritional Survey 
1988 to 1994. Among 1960 children aged 12 years who fasted 8 hours, 
two thirds had at least 1 metabolic abnormality, and nearly 1 in 10 had 
MetS. The racial/ethnic distribution was similar to adults: Mexican-
Americans, followed by non-Hispanic whites, had a greater prevalence of 
MetS compared with non-Hispanic blacks (12.9%, [95% CI 10.4% to 
15.4%]; 10.9%, [95% CI 8.4% to 13.4%]; and 2.5%, [95% CI 1.3% to 
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3.7%], respectively). Nearly one third (31.2% [95% CI 28.3% to 34.1%]) 
of overweight/obese adolescents had MetS(73) 
7.In Mohamed et al study  of 932 adolescents, aged 10–19 years, 
who had complete data and returned for reassessment 3.6 years later were 
investigated. Prevalence of metabolic syndrome according to the ATP III 
at baseline was 7.4% (95% CI 5.7–9) and after 3.6 years of follow-up was 
6.7% (5–8) .There was a significant association between metabolic 
syndrome prevalence (according to ATP III criteria) and BMI, as 57.9% 
of overweight adolescents had the metabolic syndrome compared with 
29.2% of adolescents at risk for overweight and 2.4% of adolescents with 
normal weight (P < 0.0001). High fasting triglycerides and low HDL 
cholesterol were the most prevalent components according to ATP III 
criteria (38.4 and 41.6%, respectively), whereas high fasting blood 
glucose (FBG) was the least common (1%). Lowering the FBG cut point 
from 110 to 100 mg/dl increased the percentage of subjects who met this 
standard from 1 to 7.6%, and lowering waist circumference cut point 
from the 90th percentile to the 75th percentile for sex and age increased 
the proportion of subjects who met this standard from 10.3 to 
27.3%.Overweight adolescents were 5.69 times as likely to develop 
metabolic syndrome (95% CI 2.31–13.96). Subjects with waist 
circumference more than the 90th percentile for age and sex had 2.24 
35 
 
times more chance to develop metabolic syndrome (95% CI 1.01–4.97). 
On logistic regression, no significant association was seen between FBG, 
triglycerides, HDL cholesterol, blood pressure, and age with metabolic 
syndrome incidence(74) 
8. In Martha rodriguez -Morán, study, they determined  the 
prevalence of the metabolic syndrome among children and adolescents 
aged 10–18 years from northern Mexico and evaluate a definition for its 
early diagnosis in the young population. 
Data were analyzed for 965 children and adolescents (51.7% 
female), who had an average age of 13.0 ± 2.6 years and BMI of 23.5 ± 
5.8 kg/m2. The prevalence of family history of diabetes, hypertension, 
and obesity was 43.6% (95% CI 40.5–46.8), 40.9% (37.8–44.1), and 
29.4% (26.6–32.5), respectively, and the prevalence of obesity, elevated 
blood pressure, hyperglycemia, hypertriglyceridemia, and low HDL 
cholesterol was 27.7% (24.8–30.5), 7.1% (5.5–8.8), 7.7% (6.0–9.4), 9.5% 
(7.7–11.4), and 20.8% (18.3–23.4), respectively. Diagnosis of type 2 
diabetes and hypertension was established in 17 (1.8%; 95% CI 1.0–2.8) 
and 13 (1.4%; 0.8–2.4) participants.  
Prevalence of the metabolic syndrome, according to the Adult 
Treatment Panel III, AACE, World Health Organization, EGIR, and 
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REGODCI definitions was 6.5% (95% CI 4.7–7.8), 7.7% (6.0–9.4), 4.5% 
(3.2–5.8), 3.8% (2.6–5.1), and 7.8% (6.1–9.5), respectively.  
A total of 697 (72.2%) subjects were lean; among them at least one 
family phenotype, one clinical trait, or one abnormal laboratory criterion 
was identified in 43.8, 21.3, and 20.6%. Sixty-one (8.7%) lean subjects 
fulfilled the REGODCI criterion for laboratory test, establishing 
diagnosis of the metabolic syndrome in 13 (21.3%; 95% CI 11.8–33.7) of 
them. On the other hand, diagnosis of the metabolic syndrome was 
established in 70 (26.1%; 21.0–31.5) obese children. The number of 
children and adolescents who were diagnosed with the metabolic 
syndrome was significantly lower according to the EGIR definition, 
whereas the AACE and REGODCI definitions identified the highest 
prevalence (75) 
9. Atabek ME  have studied 169 obese children and adolescents 
(body mass index>95th percentile), 100 prepubertal and 69 pubertal, aged 
between 7 and 18 years. Each subject was submitted to an oral glucose 
tolerance test. The diagnosis of impaired glucose tolerance, type 2 
diabetes and metabolic syndrome were defined according to modified 
WHO criteria adapted for children. 
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  Metabolic syndrome was found in 27.2%, with a significantly 
higher rate among adolescents aged 12-18 years (37.6%) than among 
children aged 7-11 years (20%) (p < 0.001). There were no significant 
differences in the prevalence of metabolic syndrome by sex. The 
prevalences of insulin resistance, glucose intolerance and type 2 diabetes 
were 29, 19 and 2% among prepubertal children and 56.5, 27.5 and 4.3% 
among pubertal group, respectively. The prevalence of fasting 
hyperinsulinemia in pubertal group was significantly higher than 
prepubertal children (p < 0.001). Hyperinsulinemia was also more 
frequent in pubertal children with significant difference (20% versus 
43.7%, p < 0.001). Hypertension was significantly more common in 
adolescents (31.8%) than children (15%) with obesity, as expected (p < 
0.013). Overall, dyslipidaemia in prepubertal and pubertal groups was 
identified in 42 and 55%, respectively, with no significant differences (p 
= 0.085)(76) 
10. In another study by  Calcaterra where they  studied 191 obese 
[body mass index (BMI) > 97th percentile] children and adolescents. 
Obesity was stratified on the basis of a threshold BMI z-score and 
subjects were classified as moderately (z-score 2–2·5) or severely obese 
(z-score > 2·5). Seventy-six, nonobese subjects were recruited into a 
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comparison group. Thirty-one of them were of normal weight 
(BMI < 75th percentile) and 45 overweight (BMI 75th–97th percentile). 
Patients were classified as having MS if they met three or more of 
the following criteria for age and sex: BMI > 97th percentile, triglyceride 
levels > 95th percentile, high density lipoprotein (HDL) cholesterol level 
< 5th percentile, systolic or diastolic blood pressure > 95th percentile and 
impaired glucose tolerance (blood glucose level: 7·8–11·1 mmol/l at 2 h). 
Insulin resistance was calculated using the homeostasis model assessment 
for insulin resistance (HOMA-IR) and impaired insulin sensitivity was 
defined as a HOMA-IR ≥ 2·5 in prepubertal patients and HOMA-IR > 4 
in pubertal subjects. 
  The overall prevalence of MS was 13·9% and was present in 12·0% 
of moderately obese and 31·1% of severely obese subjects; no overweight 
or normal weight subjects met the criteria for MS. The rate of the MS 
increased progressively with increasing BMI categories 
(P < 0·001).Severely obese patients had a threefold increased risk with 
respect to moderately obese patients(77) 
11.Prevalence of the Metabolic Syndrome in Iranian Adolescents* 
by Ahmad Esmaillzadeh* et al The prevalence of the metabolic syndrome 
was 10.1% (95% confidence interval: 9.0 to 11.1) among Iranian 
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adolescents (boys: 10.3% , 8.6 to 11.8; girls: 9.9% , 8.4 to 11.3). Overall, 
low serum high-density lipoprotein-cholesterol and high serum 
triglycerides were the most common components of the metabolic 
syndrome (42.8% and 37.5% , respectively). Overweight subjects had the 
highest proportion of metabolic syndrome compared with those at risk for 
overweight and those with normal weight (boys: 41.1% vs. 11.4% and 
3.0% , respectively, p < 0.01; girls: 43% vs. 15.2% and 5.0% , 
respectively, p < 0.01).  
12. Metabolic Syndrome in Overweight and Obese Japanese 
Children  by Masao Yoshinaga et al showed Japanese obese children to 
have a significantly lower prevalence (17.7%) of the metabolic syndrome 
than U.S. obese adolescents (28.7%, p = 0.0014). However, Japanese 
overweight children had a similar incidence (8.7%) of the metabolic 
syndrome compared with U.S. overweight adolescents (6.8%). 
Hyperinsulinemia in girls and abdominal obesity in boys are 
characteristic features of individual metabolic syndrome factors in 
Japanese children. 
13. Ethnic differences in metabolic syndrome among overweight 
and obese children and adolescents: the Oslo Adiposity Intervention 
Study. 
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Two hundred and three overweight and obese Norwegian, 
Pakistani, Tamil and Turkish patients aged 6-17 years living in Norway 
were included. Metabolic syndrome was defined as the presence of at 
least three abnormal values of waist circumference, blood pressure, 
fasting triglycerides, fasting glucose and HDL cholesterol. The 
prevalence of metabolic syndrome was significantly higher among the 
immigrant compared to Norwegian subjects when adjusted for age, 
gender and BMI-Z-score (20.8 vs. 30.6%; OR = 2.2, 95% CI = 1.05-
4.77). The prevalence of metabolic syndrome increased with increasing 
severity of obesity and reached 50% in severely obese immigrants and 
30% in severely obese Norwegians. Among the overweight subjects 
metabolic syndrome prevalence was 23.5% among immigrants and 19.4% 
among Norwegians. 
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STUDY JUSTIFICATION 
Childhood obesity is considered to be a disease of epidemic 
proportion. Metabolic syndrome is increasing in prevalence with 
rising childhood obesity and sedentary lifestyles. Children with 
metabolic syndrome frequently progress to type 2 DM and have 
increase risk for mortality and morbidity from cardiovascular diseases. 
Hence there is a vital need for early  identification of  children with 
this syndrome and modification of risk factors to prevent further 
progression.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIMS AND OBJECTIVES 
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AIMS AND OBJECTIVES 
• To estimate the prevalence of metabolic syndrome among 7-18yrs 
old overweight and obese children. 
• Second objective was to determine the association between insulin 
resistance and components of metabolic syndrome.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
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MATERIALS AND METHODS 
METHODOLOGY 
Study design      
             Descriptive study 
Study period:      
 October 2008 to September 2010  
Study place:  
Endocrine department of Institute of child health and hospital for 
children,  
Egmore, Chennai,  3 government and private schools. 
 
INCLUSION CRITERIA: 
Children in the age group 7 – 18 yrs who satisfy the criteria for obese 
with the BMI on CDC chart more than 95th centile 
EXCLUSION CRITERIA: 
• presence of diabetes   
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• use of drugs that alters blood pressure or glucose or lipid 
metabolism 
• syndromic obesity 
• endocrinological disorder 
Consent: 
Instituitional consent was obtained from the parents after 
explaining the nature of the study. 
MANOEUVRE: 
This cross sectional study was done in endocrinology department 
of children’s hospital egmore .children attending our OPD are screened 
for obesity with BMI, and those who satisfy the inclusion criteria were 
enrolled in the study after informing the nature of the study to the parents. 
Written informed consent was obtained from parents or guardians of 
obese patients children who were offered the study. 82 children were 
enrolled of which 35 were female and 47 were male. The same 
investigator performed anthropometric measurements and complete 
physical examination including pubertal staging, neurological, mental and 
dysmorphic findings. Obese subjects were included in study after the 
exclusion of any with endocrinological disorders or obesity syndromes. 
Tanner classification was used for pubertal staging. 
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  Information about the level of physical activity was recorded using 
a self-reporting questionnaire, including level of daily activities, time 
spent indoors watching TV, using computers, playing computer and video 
games, and studying. Birth weight, pattern of nutrition, duration of breast 
feeding and obesity, and age at onset of obesity were also assessed.  
Family history of obesity, DM, hypertension (HT), cerebrovascular 
events, coronary artery disease, dyslipidemia (DL), gestational diabetes in 
the first and second degree relatives, and educational status of the parents 
were recorded.  
Anthropometry: Body weight was measured to the nearest 0.1 kg 
with a balance scale , and height was measured to the nearest 0.1 cm with 
stadiometer  with subjects lightly dressed and without shoes. Body mass 
index (BMI) was calculated as weight (kg) divided by height square (m2). 
The mercury sphygmomanometer has  always been regarded as 
the gold standard for clinical methods.  The Korotkoff technique is used 
for measuring blood pressure Traditionally, the sounds have been 
classified as 5 phases: phase I, appearance of clear tapping sounds 
corresponding to the appearance of a palpable pulse; phase II, sounds 
become softer and longer; phase III, sounds become crisper and 
louder; phase IV, sounds become muffled and softer; and phase V, 
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sounds disappear completely. the onset of phase I corresponds to systolic 
pressure The disappearance of sounds (phase V) corresponds to diastolic 
pressure 
Since  number of factors related to the subject can cause 
significant deviations in measured blood pressure like room 
temperature, exercise, positioning of the arm, muscle tension, bladder 
distension, talking, and background  noise, the children are asked to 
remove all clothing that covers the location of cuff placement and  
comfortably seated, with the legs uncrossed, and the back and arm 
supported, such that the middle of the cuff on the upper arm is at the level 
of the right atrium (the mid-point of the sternum and are  instructed to 
relax as much as possible and to not talk during the measurement 
procedure; ideally, 5 minutes before the first reading is taken. cuff is 
deflated at the rate of 2 to 3 mm Hg per second.  A minimum of 2 
readings are  taken at intervals of at least 1 minute, and the average of 
those readings are  used to represent the patient’s blood pressure. If there 
is >5 mm Hg difference between the first and second readings, 
additional (1 or 2) readings are  obtained, and then the average of these 
multiple readings is used. Values more than 90th centile for age and sex 
considered high. 
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Laboratory investigations: Blood glucose, serum insulin and lipid 
levels were determined from blood samples taken after an overnight fast.  
Biochemical analysis and definition: 
Hyperinsulinemia is defined if fasting insulin >15mu/L, HOMA IR > 3.5 
HOMA IR is calculated as product of fasting plasma insulin in 
mu/L and the fasting glucose in mg/dl, divided by 405.Score of >3.5 is 
taken as insulin resistance and score < 3.5 as insulin sensitive. Fasting 
glucose >110mg/dl is considered abnormal and >140mg/dl is taken as 
having Diabetes mellitus 
Triglycerides >100mg/dl, HDL < 40 mg/dl is considered cut off. 
Metabolic syndrome was considered if three or more of the 
following criteria were present: BMI > 95th percentile, triglyceride 
>40mg/dl, HDL <40mg/dl, fasting glucose >110mg/dl, systolic or 
diastolic BP >90th percentile. 
Statistical analysis: 
All statistical analysis (mean, median, standard deviation) was 
done using SSPS version 11 for windows. Fisher's exact test was used to 
determine statistical differences in presence of metabolic syndrome 
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criteria according to sex and to correlate the association among insulin 
resistance presence or absence and metabolic syndrome criteria plus 
acanthosis nigricans. T test was calculated to determine statistical 
significance (p < 0.05) in clinical and biochemical characteristics 
according to sex. 
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49 
 
OBSERVATION 
Sex distribution of study population 
TABLE 1 
Male 47 (57.31) 
female                        35(42.68) 
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TABLE 2 
Clinical characteristics according to sex 
characteristics Male (N=47) 
Mean + SD 
Female(N=35) 
Mean + SD 
P VALUE * 
Age (yrs) 11.57+2.78 10.3+ 2.90 0.6 
Wt(kg) 54.10+14.16 55.72+ 13.90 0.11 
Ht(cms) 141.7+12.9 138.6+ 13..2 0.105 
BMI 26.33+2.39 25.58+ 2.33 0.3 
Systolic BP 109.8+ 13.2 107.4+12.88 0.43 
*T test is used to calculate p value 
This table depicts the clinical characteristics of male and female. No 
significant difference observed between the sex for height, weight ,BMI, 
blood pressure. Youngest female 7.2 yrs eldest 17yrs, male - youngest 
7yrs and eldest 17.8 yrs. Highest BMI in female is 30.2 against 30.3 in 
male. 
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Table 3 
Biochemical characteristics according to sex 
Characteristics  Male(N=47) 
Mean + SD 
Female(N=35) 
Mean  +SD 
P Value * 
HDL (mg/dl) 42.03+6.73 40.95+ 6.83 0.3 
LDL (mg/dl) 116.3+ 15.35 118.11+ 15.3 0.29 
TGL(mg/dl) 99.04+ 11.45 99.15+11.09 0.96 
Cholesterol(mg/dl) 158.8+ 19.13 157.13+ 19.97 0.23 
Fasting 
glucose(mg/dl) 
89.28+ 13.96 90.45+ 13.81 0.326 
Fasting 
insulin(mu/L) 
15.44+ 4.56 16.79+ 4.39 0.16 
HOMA IR 3.44+ 1.19 3.71+ 1.21 0.28 
*t test is used to calculate p value 
HDL-high density lipoprotein, LDL- low density lipoprotein, 
TGL-triglycerides, IR- insulin resistance 
             In this table showing the biochemical characteristics no 
significant p value in obtained for any criteria . HDL range 26 to 
78mg/dl, LDL range from 36 to 154mg/dl, TGL 31 to 159mg/dl, total 
cholesterol 49 to 214 mg/dl, fasting glucose 59 to 148 mg/dl,  fasting 
insulin 5 to 25.8 mu/l ,HOMA IR range from 2 to 7.1. 
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                                        Table 4 
Metabolic profile and metabolic syndrome criteria 
according to sex. 
Characteristics Male 
N ( % ) 
Female 
N ( % ) 
Total 
N ( % ) 
P 
Value* 
BMI  47(100) 35(100) 82(100) - 
IGT 1(2.1) 2(5.7) 3(3.6) 0.572 
DM - 1 (2.8) 1(1.1) 0.426 
Sys BP 15(31.9) 9(25.7) 24(29.2) 0.805 
HDL 12(25.5) 12(34.2) 24(29.2) 0.464 
TGL 16(34) 13(37.1) 29(35.3) 0.818 
HOMA IR 12(25.5) 13(37.1) 25(30.4) 0.333 
MS 13(27.6) 8(22.8) 21(25.6) 0.798 
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A.NIGRICANS 11(23.4) 13(37.1) 24(29.2) 0.222 
*fisher t test is used to calculate p value 
IGT-impaired glucose tolerance, DM-diabetes mellitus, sys BP- systolic 
blood pressure, MS- metabolic syndrome. 
The metabolic parameters does not vary with sex and there is no 
significant difference in any parameter between the groups. Of the 3 
children with impaired fasting glucose level 1 had diabetes mellitus. 21 
persons had features of metabolic syndrome of which 13 are male 8 are 
female. 
 
                                           
54 
 
 
Table 5 
Prevalence of component of metabolic syndrome according to 
insulin resistance 
characteristics Insulin 
resistance      
N=25 
  N ( % ) 
Insulin 
sensitive       
N=57 
   N ( % ) 
P Value * 
IGT 3(12) 0 0.02 
Sys BP >95th 12(48) 12(21) 0.186 
HDL 10(40) 14(24.5) 0.19 
TGL 14(54) 15(26.3) 0.012 
A.Nigricans 11(44) 13(22.8) 0.06 
*fisher t test is used to calculate p value 
Insulin resistance is significantly associated with impaired glucose 
tolerance and elevated triglycerides and acanthosis nigricans. Although 
persons with insulin resistance have higher prevalence of blood pressure 
and abnormal HDL levels they are not statistically significant. 
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Table 6 
Clustering of risk factors in the obese and non obese children 
characteristics Obese (N=82) Percentage 
No risk factors 16 19.5 
1 risk factor 32 39 
2 rick factors 13 15.8 
3 risk factors 21 25.6 
4 risk factors 0 - 
Out of the 82 obese children almost one fourth of them has 
metabolic syndrome and 39% has atleast one risk factor for 
cardiovascular disease followed in order with children having no risk 
factors and then last with 2 risk factors. None of the 82 children had all 4 
risk factors 
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DISCUSSION 
The prevalence of metabolic syndrome is reported to be 30–50% 
among obese children [14, 43]. There has been a tremendous increase in 
the number of studies on obesity and MS in children; however, there are 
conflicting results [6, 31]. This is mainly due to the lack of consensus on 
the diagnostic criteria of MS in children and adolescents. In addition to 
the previous attempts, there is now greater consensus regarding the 
components of MS during childhood and adolescence. These should 
include central obesity, insulin resistance, glucose intolerance, 
hypertension, and dyslipidemia [48]. However, this new definition using 
age-specific cutoffs has not yet resolved the issue completely, and it is 
suggested that MS should not be diagnosed in children younger than 
10 years [48]. 
The prevalence of the metabolic syndrome varies by the definitions 
used for the components and by the weight status of the subjects. Cook et 
al.,6 who studied children and adolescents 12-19 years of age in the third 
National Health and Nutrition Examination Survey (NHANES III) data 
set, reported a prevalence of 4.2%. Investigators from the Bogalusa Heart 
Study25 reported a prevalence of 3.6% in youth 8-17 years of age. 
However, researchers reported much higher prevalence rates in children 
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who are overweight or obese.6,7 In a study of 490 subjects aged 4-20 
years, 89% of whom had a BMI ≥ 97th percentile, the prevalence of the 
metabolic syndrome in moderately obese subjects (defined as a BMI z-
score of 2.0-2.5) was 38.7%, whereas almost half (49.7%) of severely 
obese subjects (defined as a BMI z-score > 2.5) had the syndrome.7 In 
another study among children and adolescents 8-19 years of age, the 
prevalence was 6.8% in those who were at risk for overweight (85-95th 
percentile of BMI) and 28.7% in those who were overweight (BMI ≥ 95th 
percentile).8 
The prevalence of the metabolic syndrome in youth may vary by 
sex and ethnicity, as it does in adults, but data on this are conflicting. In a 
national multiethnic study, the metabolic syndrome was significantly 
more prevalent in males (6.1%) than in females (2.1%),6 but other 
researchers reported no significant sex differences.8 Cook et al.6 reported 
the prevalence of the metabolic syndrome was higher in whites (4.8%) 
and Mexican Americans (5.6%) than in African Americans (2.0%). Weiss 
et al.7 also found that white children were at greater risk for metabolic 
syndrome than were African-American children when they used the same 
cut points for lipids. However, when they used race-specific norms for 
lipids, the prevalence of the metabolic syndrome risk did not differ 
between African-American and white youth, likely because the African-
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American youth had better lipid profiles. More large, multiethnic studies 
with boys and girls are needed to learn whether the ethnic and sex 
differences seen in the metabolic syndrome in adults are also present 
during childhood and adolescence. 
The prevalence of metabolic syndrome in obese children in  this 
study  conducted in children’s hospital is 25.6 %  which is similar to the 
prevalence of metabolic syndrome in Hispanic youth study by Martha et 
al. This result suggests that MS has become a serious problem in our 
country. In the literature, there are diverse statements on the impact of 
gender and puberty on the prevalence of MS [4, 16, 17, 41]. Cook et al. 
[14], Cruz et al. [16], and Weiss et al. [43] reported a higher prevalence 
of MS and its components in male compared to female children. In this 
study no such sex difference was noticed. 
The prevalence of hypertension and dyslipidemia in the form of 
elevated triglycerides and low HDL are 29.2%, 29.2% and35.3% 
respectively. Only 3.6% had impaired glucose concentration of which 1 
had frank diabetes mellitus. In a study by Viner et al. [41], the prevalence 
of dyslipidemia, HT, IGT, and elevated fasting insulin were  30%, 32%, 
11%, and 0.8%, respectively, while type 2 DM was not observed in any 
patient [41]. This is almost comparable to this study. The prevalence of 
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IGT and type 2 DM in European obese children and adolescents were 
7.5% and 1.2%, respectively [45]. In Italy, the corresponding prevalences 
were 4.5%, and 0.1%, respectively [24]. The prevalence of type 2 DM in 
Germany (1.5%) was higher than that in Sweden (0.5%), with the 
prevalence of IGT (20–25%) and type 2 DM (4%) being highest in the 
US [36, 42, 46].  
The prevalence of CV risk factors in obese children can change 
because of varying diagnostic criteria and cut-off values used in different 
studies [16, 17]. According to Viner et al.’s study [41], the prevalence of 
the presence of two risk factors in obese children, aged 2–18 years, was 
36%, while the prevalence of patients with three and four risk factors 
were 28% and 5%, respectively. In another study done in turkey by yasar 
sen , the prevalence of children with two CV risk factors was 37.5%, 
while with three and four risk factors were found to be 31.5% and 10.3%, 
respectively. In our study the  results are 31.7% with 1 risk factor and 
28% , 25.6% with 2 and 3 risk factors respectively similar to those of the 
study by Viner et al. [41]. 
Impaired glucose tolerance was more common in persons with 
insulin resistance than in persons with insulin sensitivity as shown by 
significant p value. Similarly hypertriglyceridemia was significantly 
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associated with insulin resistance. Other parameters like HDL 
abnormality or hypertension was not observed to have significant relation 
with insulin resistance when individual components were considered. 
Our study provides evidence showing a high prevalence of the 
metabolic syndrome in obese adolescents and children. Further study 
could better show the pathophysiology of metabolic syndrome in 
adolescents and its relationship to other chronic diseases. 
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SUMMARY AND CONCLUSION 
o In this study the prevalence of metabolic syndrome in obese 
children is  25.6%. 
o The percentage of obese children with hypertension, elevated 
triglycerides and low high density cholesterol are 29.2%, 29.2%, 
35.3% respectively. 
o 3.6% has impaired glucose tolerance, and 1 child has frank type 2 
diabetes mellitus. 
o This high prevalence of metabolic syndrome signifies the need for 
early screening of obese children for components of metabolic 
syndrome. 
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ANNEXURE 
 
PROFORMA 
 
REG NO: 
 
NAME: 
 
AGE/SEX: 
 
ADDRESS: 
 
 
 
Age of onset of obesity: 
 
Onset:  
 
Progression: 
 
Hours of television watching 
80 
 
Per day:                                                                 per week: 
 
Hours of exercise  
Per day:                                                                 per week:  
 
Frequency of eating junk foods: 
 
SYMPTOMS OF HYPOTHYROIDISM: 
Lethargy 
Cold intolerance  
Constipation 
Poor school performance 
Neck swelling 
 
FAMILY H/O  
Obesity                                                          
Diabetes  
Hypertension 
Coronary artery disease 
 
History of  drug intake: 
EXAMINATION:  
 
Height: 
81 
 
                                                                                                         BMI: 
Weight: 
 
 
Blood pressure:                1ST                       2ND                   Mean BP: 
 
Pulse rate: 
 
Waist circumference: 
 
Acanthosis nigricans : 
 
Neck swelling: 
 
Dry skin: 
 
 
INVESTIGATIONS: 
 
Fasting glucose: 
 
Fasting triglycerides: 
 
Fasting HDL: 
82 
 
 
Fasting LDL: 
 
Fasting serum insulin: 
 
HOMA  IR: 
 
Thyroid function test: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
